Clinical Trial Update: A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Ginkgolides Diterpene Lactone Meglumine Injection for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgolides Diterpene Lactone Meglumine Injection

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED